Macular hole surgery and cataract extraction: combined vs consecutive surgery.
OBJECTIVE
To compare the functional and the anatomic outcomes of a combined surgery and consecutive surgery for macular hole and cataract extraction.


METHODS
Multicenter, retrospective, comparative case series.


METHODS
One hundred twenty patients (120 eyes) with an idiopathic macular hole and cataract were operated on in 1 or 2 sessions in 2 academic centers, Dijon University Hospital and Nancy University Hospital. Combined surgery (n = 64) and consecutive surgery (n = 56) were performed between 2006 and 2007. All patients underwent pars plana vitrectomy with internal limiting membrane peeling and gas tamponade. Cataract extraction was performed with phacoemulsification followed by a posterior chamber intraocular lens implantation. The main outcome measures were near and far visual acuity at 6 and 12 months, and the rate of closure of macular hole evaluated with optical coherence tomography.


RESULTS
After a 12-month follow-up, the postoperative best-corrected visual acuities significantly improved in both the combined and the consecutive surgery groups (near and far vision in both groups, P < .0001). However the improvement of far visual acuity was not significant in the consecutive surgery group at 6 months (P = .06) while such an improvement was observed in the combined surgery group (P < .0001). The rates of closure, 100% and 96% in the combined and the consecutive groups respectively, and the complications did not differ significantly between groups.


CONCLUSIONS
Both combined and consecutive surgeries are safe and effective methods to treat macular hole and cataract with equivalent functional and anatomic results in both procedures. However, combined surgery shortened the delay for visual recovery.
Muselier
Aurore
A
Department of Ophthalmology University Hospital, Rue du Faubourg Raines, Dijon, France.
Dugas
Brice
B
Burelle
Xavier
X
Passemard
Marie
M
Hubert
Isabelle
I
Mathieu
Bénigne
B
Berrod
Jean Paul
JP
Bron
Alain M
AM
Creuzot-Garcher
Catherine
C
D000368:Aged; D000369:Aged, 80 and over; D002386:Cataract / Q000150:complications*; D017679:Cryotherapy; D005260:Female; D005466:Fluorocarbons / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D019654:Lens Implantation, Intraocular; D008297:Male; D008875:Middle Aged; D018918:Phacoemulsification; D012167:Retinal Perforations / Q000150:complications* / Q000601:surgery*; D012189:Retrospective Studies; D013459:Sulfur Hexafluoride / Q000008:administration & dosage; D041623:Tomography, Optical Coherence; D014792:Visual Acuity / Q000502:physiology; D014821:Vitrectomy
D005466:Fluorocarbons; C048381:perfluoroethane; C042852:perflutren; D013459:Sulfur Hexafluoride